About The Study: This study provides evidence for a sensorimotor cortical biomarker signature for pain sensitivity. The combination of accuracy, reproducibility, and reliability suggests the peak alpha frequency/corticomotor excitability biomarker signature has substantial potential for clinical translation, including predicting the transition from acute to chronic pain.
Corresponding Author: To contact the corresponding author, David A. Seminowicz, PhD, email dseminow@uwo.ca .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaneurol.2024.4857)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2024.4857?guestAccessKey=4e166dca-7877-4635-b8d1-9fcfef730dfa&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=012725
JAMA Neurology